Article Details
Retrieved on: 2023-01-04 08:06:18
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Allen & Overy advised Shandong Boan Biotechnology Co., Ltd. on the deal.The transaction involed the spin-off from Luye Pharma Group (2186.
Article found on: globallegalchronicle.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here